Viatris (VTRS) Deferred Taxes (2019 - 2026)
Viatris' (VTRS) quarterly Deferred Taxes came in at -$69.7 million in Q1 2026, down 59.86% year-on-year from -$173.7 million in Q1 2025, and up 71.92% quarter-over-quarter from -$248.2 million in Q4 2025.
Viatris (VTRS) Deferred Taxes (2019 - 2026) Analysis & Trends
Viatris' Deferred Taxes history runs 8 years deep, the most recent figure standing at -$69.7 million for Q1 2026.
- On a quarterly basis, Deferred Taxes fell 59.86% year-over-year to -$69.7 million in Q1 2026; TTM through Mar 2026 was -$502.6 million, a 33.81% increase from a year earlier, with the FY2025 full-year figure at -$476.5 million, up 37.92% from the prior year.
- Deferred Taxes grew to -$69.7 million in Q1 2026 per VTRS's latest filing, from -$248.2 million in the prior quarter.
- Across five years, Deferred Taxes topped out at $153.6 million in Q4 2022 and bottomed at -$312.4 million in Q3 2024.
- The 5-year median for Deferred Taxes is -$69.7 million (2026), against an average of -$101.6 million.
- Across the five-year window, Deferred Taxes soared 390.36% in 2022 and sank 288.13% in 2023, its largest moves.
- Year by year, Deferred Taxes stood at $153.6 million in 2022, then slumped by 234.9% to -$207.2 million in 2023, then fell by 20.13% to -$248.9 million in 2024, then increased by 0.28% to -$248.2 million in 2025, then surged by 71.92% to -$69.7 million in 2026.
- Per Business Quant, the three latest VTRS Deferred Taxes figures stand at -$69.7 million (Q1 2026), -$248.2 million (Q4 2025), and -$137.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -22.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 34.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 25.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -69.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -61.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 2.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -69.70 Mn |
| Dec 31, 2025 | -248.20 Mn |
| Sep 30, 2025 | -137.20 Mn |
| Jun 30, 2025 | -47.50 Mn |
| Mar 31, 2025 | -43.60 Mn |
| Dec 31, 2024 | -248.90 Mn |
| Sep 30, 2024 | -312.40 Mn |
| Jun 30, 2024 | -154.40 Mn |
| Mar 31, 2024 | -51.90 Mn |
| Dec 31, 2023 | -207.20 Mn |
| Sep 30, 2023 | -85.00 Mn |
| Jun 30, 2023 | -68.20 Mn |
| Mar 31, 2023 | -26.70 Mn |
| Dec 31, 2022 | 153.60 Mn |
| Sep 30, 2022 | -21.90 Mn |
| Jun 30, 2022 | -104.80 Mn |
| Mar 31, 2022 | -52.80 Mn |
| Dec 31, 2021 | -52.90 Mn |
| Sep 30, 2021 | 147.00 Mn |
| Jun 30, 2021 | 293.20 Mn |